Marc Alizon

This inventor holds 62 USPTO granted patents, plus 3 CIPO patents and 2 EPO patents, primarily in HIV Diagnostics (CPC class 5303). Top assignees: Institut Pasteur, Centre National De La Recherche Scientifique, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 1991-2013.

USPTO Granted Patents = 62

% Patents Active = 88.7

CIPO Patents = 3

EPO Patents = 2

Average Co-Inventor Count = 5.7

ph-index = 10

Forward Citations = 353(Granted Patents)

Forward Citations (Not Self Cited) = 299(Dec 10, 2025)

Inventors with similar research interests:

Location History:

75005 Paris, FR (2001)
Paris, FR (1991 - 2013)

Company Filing History:

Centre National De La Recherche Scientifique

patents

2 out of 3,690

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

4. 6 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 1991-2013

Loading Chart...

Areas of Expertise:

Nucleic Acid Probes

HIV-1 Detection

HIV-2 Antigens

Cloned DNA Sequences

Peptides

Diagnostic Kits

Reverse Transcriptase

In Vitro Methods

Antibodies

Viral Extracts

Polypeptides

RNA Detection

62 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8507196 - Nucleic acid probe of human immunodeficiency virus type 1 (HIV-1), and a method and kit employing this probe for detecting the presence of nucleic acid of HIV-1 (2013-08-13),

2. 8329396 - Cloned DNA sequences hybridizable with genomic RNA of lymphadenopathy associated virus (LAV) (2012-12-11),

3. 7767800 - [object Object] (2010-08-03),

4. 7626013 - HIV-1 DNA fragments that hybridize to genomic HIV-1DNA (2009-12-01),

5. 7585619 - Method for detecting human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) activity (2009-09-08),

6. 7351412 - Cloned DNA sequences related to the genomic RNA of lymphadenopathy-associated-virus (LAV) and proteins encoded by said LAV genomic RNA (2008-04-01),

7. 7341731 - HIV-2 antigen compositions (2008-03-11),

8. 7232654 - DNA sequence of the LTR region of human immunodeficiency virus type 1 (HIV-1) (2007-06-19),

9. 7217508 - Cloned DNA sequence related to genomic RNA of human immunodeficiency virus (HIV-1) (2007-05-15),

10. 7119181 - DNA sequences and peptides of human immunodeficiency virus (HIV-1) (2006-10-10),

11. 7115363 - Retrovirus capable of causing AIDS, means and methods for detecting it in vitro (2006-10-03),

12. 7045130 - Antibodies against antigens of human immunodeficiency virus (HIV-1) (2006-05-16),

13. 7029679 - Variant of LAV viruses (2006-04-18),

14. 6979535 - Human immunodeficiency virus type 2 (HIV-2) env polypeptide and diagnostic assays (2005-12-27),

15. 6951648 - Variant of LAV viruses (2005-10-04),

Title: Marc Alizon - Innovative Inventor from Paris

Introduction: Marc Alizon is a renowned inventor based in Paris, France, known for his groundbreaking contributions to various industries.

Latest Patents: Marc Alizon holds several patents in the fields of technology, healthcare, and sustainable energy, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Marc Alizon has consistently pushed the boundaries of innovation, leading to the development of cutting-edge solutions that have revolutionized the way we live and work.

Collaborations: Throughout his career, Marc Alizon has collaborated with leading research institutions, universities, and multinational companies, fostering a culture of innovation and knowledge-sharing.

Conclusion: Marc Alizon's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs worldwide.